128

Publikationen

Filtern nach:

Filter zurücksetzen

Anzahl gefilterter
Ergebnisse:

CF. Vogelmeier, N. Kossack, N. Kolb, C. Nordon, K. Rhodes, M. Abram, M. Halbach, M. Gediga. Healthcare resource utilisation in COPD patients experiencing severe cardiac events: Results from EXACOS-CV studies in Germany. Kongress der Deutschen Gesellschaft für Pneumologie (DGP), Mannheim, March 20, 2024 No DOI/URL available

Therapy areas: Respiratory

Indications: COPD

Kliemt, R., Claus, F., Weinhold, I., Baum, F., March, S., Neumann, A., Schoffer, O., Seifert, M., Swart, E., Schmitt, J. M. & Häckl, D. (2018). Gesundheitsökonomische Evaluation von Modellprojekten zur Versorgung psychisch kranker Menschen nach §64b SGB V – erste Ergebnisse von 12 Kliniken. In: Deutsches Netzwerk Versorgungsforschung e. V. (Hrsg.). 17. Deutscher Kongress für Versorgungsforschung, 10.–12.10.2018, Berlin. DOI:https://doi.org/10.3205/18DKVF065.

Therapy areas: Psychiatry

Indications: Mental disorders

Edward R Hammond, Heiko Friedel, Elena Garal-Pantaler, Marc Pignot, Erica Velthuis, Xia Wang, Henk Nab, Barnabas Desta, Andreas Schwarting. Health Care Costs of Patients With Systemic Lupus Erythematosus (SLE) Versus Control Patients as a Function of Disease Severity: Analysis of the Betriebskrankenkassen German Sickness Fund. ACR/ARHP Annual Meeting 2017, San Diego No DOI/URL available

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

ER Hammond, H Friedel, E Garal-Pantaler, M Pignot, E Velthuis, X Wang, H Nab, B Desta, A Schwarting. Health Care Resource Use (HRU) and Medical Costs Analyses as a Function of Systemic Lupus Erythematosus (SLE) Disease Severity: Analysis of Claims Data of a German Sickness Fund. LUPUS 2018;5(Suppl 1):A1–A129,  DOI: 10.1136/lupus-2018-abstract.204

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Parsekar, K., Kossack, N., Hernández, I., Vogelmeier, C. F., Kolb, N., Baak, B. N., Swart-Polinder, K. M. A., Simons, S. O., Bengtsson, C., Vojinovic-Dees, D., Sin, D. D., Hawkins, N. M., McMullen, S., Pham, T., Corregidor García, C., Martinez, N., Sánchez-Covisa Hernández, J., Abram, M., Halbach, M., van Burk, L., Randhawa, A. & Nordon, C. (2023). Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from EXACOS-CV Studies in Spain, Germany, the Netherlands and Canada. [Vortrag]. ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen. Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3784/129353 (abgerufen am 03.01.2024).

Therapy areas: Respiratory

Indications: COPD

Bo Ding, Marc Pignot, Elena Garal-Pantaler, Beate Villinger, Barnabas Desta, Katharina Schmidt, Sarowar Golam, Heide Stirnadel-Farrant, Andreas Schwarting Clinical Characteristics,  Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany  EULAR 2022 No DOI/URL available

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Neumann, A., Hense, H., Baum, F., Kliemt, R., Seifert, M., Harst, L., Kubat, D., Maicher, B., Schrey, C., Schmitt, J. M., Pfennig, A., Weinhold, I., Swart, E. & Soltmann, B. (2021). Evaluation of a flexible and integrative psychiatric care model in a department of child and adolescent psychiatry in Tübingen, Germany: study protocol (EVA_TIBAS). BMC health services research, 21(1), S. 1262. DOI:https://doi.org/10.1186/s12913-021-07226-1.

Therapy areas: Psychiatry

Indications: Mental disorders

Grellmann, C., Dombrowsky, W., Fabricius, V., Suruki, R., Sheahan, A. & Joeres, L. (2021). Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.  Adv Ther. (Advances in Therapy), 38(1), S. 366–385. DOI:https://doi.org/10.1007/s12325-020-01522-8 (abgerufen am 06.11.2023).

Harrow B, Konieczny A, Pignot M, Wilk A, Bala M. Disease Burden During The “Watchful Waiting” Period In Women With Recurrent Ovarian Cancer In Germany. Value in Health 2017 VOLUME 20, ISSUE 9, PA465-A466. DOI:https://doi.org/10.1016/j.jval.2017.08.381

Therapy areas: Oncology/Hematology

Indications: Ovarian Cancer

K.I. Birkeland, Johan Bodegard, Jan W Eriksson, Anna Norhammar, Marcus Thuresson, Marc Pignot, Nils Kossack, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki, Dörte Anderson. Das kardiorenale Syndrom ist die häufigste erste kardiovaskuläre Manifestation beim Typ-2-Diabetes und mit erhöhter Mortalität assoziiert: eine große multinationale Beobachtungsstudie  DDG 2020 No DOI/URL available

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Diabetes Type 2

Balfanz, P., Hartmann, B., Müller-Wieland, D., Kleines, M., Häckl, D., Kossack, N., Kersten, A., Cornelissen, C., Müller, T., Daher, A., Stöhr, R., Bickenbach, J., Marx, G., Marx, N. & Dreher, M. (2021). Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19.  PLoS ONE, 16(1), S. e0246182. DOI:https://doi.org/10.1371/journal.pone.0246182.

Therapy areas: Infectious Diseases

Indications: COVID-19

Schultze M, Garal-Pantaler E, Pignot M, Carnarius H, Gairy K, Levy R. Economic Burden of Organ Damage in Systemic Lupus Erythematosus: Results From a German Claims Analysis. DGRh Kongress 2021. doi: 10.3205/21dgrh064

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Weinhold, I., Schindler, C., Kossack, N., Berndt, B. & Häckl, D. (2019). Economic impact of disease prevention in a morbidity-based financing system: does prevention pay off for a statutory health insurance fund in Germany?  The European journal of health economics : HEPAC : health economics in prevention and care, 20(8), S. 1181–1193. DOI:https://doi.org/10.1007/s10198-019-01086-7 (abgerufen am 18.09.2023).

Therapy areas: General Health

Indications: General

Vogelmeier, C. F., Rhodes, K., Garbe, E., Abram, M., Halbach, M., Müllerová, H., Kossack, N., Timpel, P., Kolb, N. & Nordon, C. (2024). Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany.  BMJ open respiratory research, 11(1). DOI: https://doi.org/10.1136/bmjresp-2023-002153.

Therapy areas: Respiratory

Indications: COPD

Ständer, S., Ketz, M., Kossack, N., Akumo, D., Pignot, M., Gabriel, S. & Chavda, R. (2020). Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.  Acta Derm Venereol. (Acta Dermato-Venereologica), 100(18), S. adv00309. DOI:https://doi.org/10.2340/00015555-3655 (abgerufen am 02.11.2023).

Therapy areas: Dermatology

Indications: Prurigo Nodularis

Rajeev Chavda, Sylvie Gabriel, Marc Pignot, Miriam Ketz, Patricia Medina, Ester Rita Alessandrini, Ikbel Amri, Sonja Ständer. Epidemiology of prurigo nodularis among SHI insured patients in germany: a claims database analysis ISPOR Europe 2019, Copenhagen, Denmark No DOI/URL available Prurigo Nodularis

Indications: Dermatology

Sonja Ständer, Miriam Ketz, Nils Kossack, Marc Pignot, Rajeev Chavda, Sylvie Gabriel. Disease Burden, Healthcare Resource Utilization & Treatment Pattern among Patients with Prurigo Nodularis compared to a Benchmark in Germany: A Real-World-Evidence Claims Data Study. 31st EADV Congress, Milan 2022. No DOI/URL available

Therapy areas: Dermatology

Indications: Prurigo Nodularis

Pignot M, Kossack N, Shi-van Wielink K. Cross Sectional Claims Data Analysis on Myopia Epidemiology and Treatment Options in Germany. Value in Health, Volume 26, Issue 11, S2 (December 2023). No DOI/URL available

Therapy areas: Ophthalmology

Indications: Myopia

Pavo Marijic, Roman Kliemt, Martin Krammer, Nikolaus Kolb, Theo Last, Maria Waize, Manuela Stierl, Maria João Fonseca, Alen Marijam. Costs and Complications of RSV in the Older Adult Population: A German Claims Database Analysis.16th dggö Annual Conference 2024, 04 March 2024, Halle, Germany No DOI/URL available RSV

Indications: Infectious Diseases

1234567